Marko Babjuk

17.7k total citations · 10 hit papers
79 papers, 10.9k citations indexed

About

Marko Babjuk is a scholar working on Surgery, Urology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Marko Babjuk has authored 79 papers receiving a total of 10.9k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Surgery, 33 papers in Urology and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Marko Babjuk's work include Bladder and Urothelial Cancer Treatments (64 papers), Urinary and Genital Oncology Studies (59 papers) and Urological Disorders and Treatments (27 papers). Marko Babjuk is often cited by papers focused on Bladder and Urothelial Cancer Treatments (64 papers), Urinary and Genital Oncology Studies (59 papers) and Urological Disorders and Treatments (27 papers). Marko Babjuk collaborates with scholars based in Czechia, Germany and France. Marko Babjuk's co-authors include Richard Sylvester, Morgan Rouprêt, Shahrokh F. Shariat, Eero Kaasinen, Andreas Böhle, Éva Compérat, Bas W.G. van Rhijn, Richard Zigeuner, Maximilian Burger and Joan Palou and has published in prestigious journals such as The Journal of Urology, International Journal of Cancer and European Urology.

In The Last Decade

Marko Babjuk

70 papers receiving 10.8k citations

Hit Papers

EAU Guidelines on Non–Muscle-invasive Urothelial... 2008 2026 2014 2020 2016 2015 2013 2019 2021 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
    2016 1.5k citations Marko Babjuk, Andreas Böhle et al. European Urology profile →
  2. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update
    2015 1.1k citations Morgan Rouprêt, Marko Babjuk et al. European Urology profile →
  3. EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
    2013 927 citations Marko Babjuk, Maximilian Burger et al. European Urology profile →
  4. European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update
    2019 893 citations Marko Babjuk, Maximilian Burger et al. European Urology profile →
  5. European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)
    2021 860 citations Marko Babjuk, Maximilian Burger et al. European Urology profile →
  6. EAU Guidelines on Non–Muscle-Invasive Urothelial Carcinoma of the Bladder, the 2011 Update
    2011 785 citations Marko Babjuk, Willem Oosterlinck et al. European Urology profile →
  7. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update
    2020 561 citations Morgan Rouprêt, Marko Babjuk et al. European Urology profile →
  8. EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder
    2008 529 citations Marko Babjuk, Willem Oosterlinck et al. European Urology profile →
  9. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update
    2017 515 citations Morgan Rouprêt, Marko Babjuk et al. European Urology profile →
  10. Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)
    2016 261 citations Francesco Soria, Shahrokh F. Shariat et al. World Journal of Urology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marko Babjuk Czechia 32 9.7k 3.0k 1.9k 1.9k 1.6k 79 10.9k
Joan Palou Spain 44 10.3k 1.1× 3.4k 1.1× 2.0k 1.0× 2.3k 1.2× 1.8k 1.1× 300 12.0k
Bas W.G. van Rhijn Netherlands 41 11.0k 1.1× 3.1k 1.0× 2.3k 1.2× 2.2k 1.2× 2.7k 1.7× 141 12.5k
H. Barton Grossman United States 53 7.7k 0.8× 2.0k 0.7× 2.2k 1.1× 1.8k 1.0× 2.8k 1.8× 194 10.6k
Nigel C. Cowan United Kingdom 30 7.9k 0.8× 2.6k 0.9× 1.7k 0.9× 2.8k 1.5× 1.7k 1.1× 62 9.9k
Maria De Santis Italy 46 6.2k 0.6× 1.5k 0.5× 2.5k 1.3× 2.2k 1.2× 1.8k 1.1× 217 10.2k
Sam S. Chang United States 45 4.9k 0.5× 1.9k 0.6× 2.4k 1.3× 3.1k 1.7× 2.2k 1.4× 209 9.9k
H. Barton Grossman United States 50 6.6k 0.7× 2.1k 0.7× 1.8k 0.9× 1.8k 1.0× 2.8k 1.8× 212 10.0k
Per‐Uno Malmström Sweden 44 5.4k 0.6× 1.5k 0.5× 1.8k 0.9× 1.3k 0.7× 2.1k 1.3× 215 7.9k
Eero Kaasinen Finland 24 6.1k 0.6× 2.0k 0.6× 1.2k 0.6× 1.0k 0.6× 1.1k 0.7× 39 6.8k
Richard Zigeuner Austria 54 10.3k 1.1× 2.9k 1.0× 3.1k 1.6× 5.0k 2.7× 3.1k 2.0× 196 14.3k

Countries citing papers authored by Marko Babjuk

Since Specialization
Citations

This map shows the geographic impact of Marko Babjuk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marko Babjuk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marko Babjuk more than expected).

Fields of papers citing papers by Marko Babjuk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marko Babjuk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marko Babjuk. The network helps show where Marko Babjuk may publish in the future.

Co-authorship network of co-authors of Marko Babjuk

This figure shows the co-authorship network connecting the top 25 collaborators of Marko Babjuk. A scholar is included among the top collaborators of Marko Babjuk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marko Babjuk. Marko Babjuk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Laukhtina, Ekaterina, Paolo Gontero, Marko Babjuk, et al.. (2024). Adjuvant intravesical therapy in intermediate‐risk non‐muscle‐invasive bladder cancer. British Journal of Urology. 134(4). 644–651. 2 indexed citations
2.
Lobo, Niyati, Nathan A. Brooks, Alexandre R. Zlotta, et al.. (2021). 100 years of Bacillus Calmette–Guérin immunotherapy: from cattle to COVID-19. Nature Reviews Urology. 18(10). 611–622. 104 indexed citations
3.
Babjuk, Marko, Maximilian Burger, Otakar Čapoun, et al.. (2021). European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ). European Urology. 81(1). 75–94. 860 indexed citations breakdown →
4.
5.
Mari, Andrea, Shoji Kimura, Beat Foerster, et al.. (2018). A systematic review and meta‐analysis of the impact of lymphovascular invasion in bladder cancer transurethral resection specimens. British Journal of Urology. 123(1). 11–21. 46 indexed citations
6.
Compérat, Éva, Maximilian Burger, Paolo Gontero, et al.. (2018). Grading of Urothelial Carcinoma and The New “World Health Organisation Classification of Tumours of the Urinary System and Male Genital Organs 2016”. European Urology Focus. 5(3). 457–466. 106 indexed citations
7.
Mulders, Peter F.A., Luis Martínez‐Piñeiro, Axel Heidenreich, et al.. (2018). Adjuvant recMAGE-A3 Immunotherapy After Cystectomy for Muscle-invasive Bladder Cancer: Lessons Learned from the Phase 2 MAGNOLIA Clinical Trial. European Urology Focus. 5(5). 849–852. 3 indexed citations
8.
Pešl, Michael, Viktor Soukup, Marko Babjuk, et al.. (2015). Význam stanovení močové hladiny TATI (tumour associated trypsin inhibitor) pro diagnostiku a prognózu tumorů močového měchýře. 19(1). 44–50. 1 indexed citations
9.
Rouprêt, Morgan, Marko Babjuk, Éva Compérat, et al.. (2015). European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update. European Urology. 68(5). 868–879. 1066 indexed citations breakdown →
10.
Klatte, Tobias, Évanguelos Xylinas, Malte Rieken, et al.. (2014). Effect of ABO blood type on mortality in patients with urothelial carcinoma of the bladder treated with radical cystectomy. Urologic Oncology Seminars and Original Investigations. 32(5). 625–630. 20 indexed citations
11.
Soukup, Viktor, et al.. (2013). Exprese genů BCL-2 a BAX-1 ve tkáni Ta, T1 uroteliálních karcinomů močového měchýře a jejich prognostický význam. 17(3). 204–209. 1 indexed citations
12.
Babjuk, Marko, W. Oosterlinck, Richard Sylvester, et al.. (2012). Guía clínica del carcinoma urotelial de vejiga no músculo-invasivo de la Asociación Europea de Urología. Actualización de 2011: Actualización de 2011. Actas Urológicas Españolas. 36(7). 389–402. 10 indexed citations
13.
Veselý, Štěpán, et al.. (2012). Parameters derived from the postoperative decline in ultrasensitive PSA improve the prediction of radical prostatectomy outcome. World Journal of Urology. 31(2). 299–304. 14 indexed citations
14.
Soukup, Viktor, Marko Babjuk, Joaquim Bellmunt, et al.. (2012). Follow-up After Surgical Treatment of Bladder Cancer: A Critical Analysis of the Literature. European Urology. 62(2). 290–302. 97 indexed citations
15.
Hora, Milan, Viktor Eret, Ondřej Hes, et al.. (2011). Integrace chirurgické a biologické léčby u pokročilého renálního karcinomu. 15(3). 149–157.
16.
Pešl, Michael, et al.. (2011). Hodnocení významu klinicko-patologických prognostických faktorů u nádorů močového měchýře neinfiltrujících svalovinu. 15(4). 222–228.
17.
Rouprêt, Morgan, Richard Zigeuner, Juan Palou, et al.. (2011). European Guidelines for the Diagnosis and Management of Upper Urinary Tract Urothelial Cell Carcinomas: 2011 Update. European Urology. 59(4). 584–594. 293 indexed citations
18.
Babjuk, Marko. (2009). Transuretrální resekce v léčbě neinvazivních a povrchově invazivních (Ta, T1) nádorů močového měchýře. 18(4). 167–171.
19.
Babjuk, Marko, Willem Oosterlinck, Richard Sylvester, et al.. (2009). Guía clínica del carcinoma urotelial no músculo invasivo de la Asociación Europea de Urología. Actas Urológicas Españolas. 33(4). 361–371. 14 indexed citations
20.
Schultz, Iman J., Kenneth Wester, Huub Straatman, et al.. (2006). Prediction of recurrence in Ta urothelial cell carcinoma by real‐time quantitative PCR analysis: A microarray validation study. International Journal of Cancer. 119(8). 1915–1919. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joan Palou Breakdown of academic impact, for papers by Bas W.G. van Rhijn Breakdown of academic impact, for papers by H. Barton Grossman Breakdown of academic impact, for papers by Nigel C. Cowan Breakdown of academic impact, for papers by Maria De Santis Breakdown of academic impact, for papers by Sam S. Chang Breakdown of academic impact, for papers by H. Barton Grossman Breakdown of academic impact, for papers by Per‐Uno Malmström Breakdown of academic impact, for papers by Eero Kaasinen Breakdown of academic impact, for papers by Richard Zigeuner
Rankless by CCL
2026